APA (7th ed.) Citation

EJ, J., YS, K., Y, L., JS, R., YH, C., & E, K. (2026). SFXN3 Serves as a Predictive Biomarker for Cisplatin Response and Survival in Head and Neck Squamous Cell Carcinoma. Oncology research, 34(6), 22. https://doi.org/10.32604/or.2026.078376

Chicago Style (17th ed.) Citation

EJ, Jeong, Kim YS, Lee Y, Ryu JS, Choi YH, and Kim E. "SFXN3 Serves as a Predictive Biomarker for Cisplatin Response and Survival in Head and Neck Squamous Cell Carcinoma." Oncology Research 34, no. 6 (2026): 22. https://doi.org/10.32604/or.2026.078376.

MLA (9th ed.) Citation

EJ, Jeong, et al. "SFXN3 Serves as a Predictive Biomarker for Cisplatin Response and Survival in Head and Neck Squamous Cell Carcinoma." Oncology Research, vol. 34, no. 6, 2026, p. 22, https://doi.org/10.32604/or.2026.078376.